Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis

被引:111
|
作者
Goldman, Jeremy
Rutkowski, Joseph M.
Shields, Jacqueline D.
Pasquier, Miriella C.
Cui, Yingjie
Schmoekel, Hugo G.
Willey, Stephen
Hicklin, Daniel J.
Pytowski, Bronislaw
Swartz, Melody A.
机构
[1] Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Life Sci, LMBM, CH-1015 Lausanne, Switzerland
[2] Tumor Biol ImClone Syst, New York, NY USA
[3] ImClone Syst, Expt Therapeut, New York, NY USA
来源
FASEB JOURNAL | 2007年 / 21卷 / 04期
关键词
VEGF-C; mouse; in vitro wound healing; vasculogenesis;
D O I
10.1096/fj.06-6656com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of vascular endothelial growth factor ( VEGF) receptor-3 (VEGFR-3) by VEGF-C initiates lymphangiogenesis by promoting lymphatic proliferation and migration. However, it is unclear whether VEGFR-3 signaling is required beyond these initial stages, namely during the organization of new lymphatic endothelial cells (LECs) into functional capillaries. Furthermore, the role of VEGFR-2, which is also expressed on LECs and binds VEGF-C, is unclear. We addressed these questions by selectively neutralizing VEGFR-3 and/or VEGFR-2 for various time periods in an adult model of lymphangiogenesis in regenerating skin. While blocking either VEGFR-2 or VEGFR-3 with specific antagonist mAbs (DC101 and mF4-31C1, respectively) prior to lymphatic migration prevented lymphangiogenesis, blocking VEGFR-3 subsequent to migration did not affect organization into functional capillaries, and VEGFR-2 blocking had only a small hindrance on organization. These findings were confirmed in vitro using human LECs and anti-human antagonist mAbs (IMC-1121a and hF4-3C5): both VEGFR-2 and VEGFR-3 signaling were required for migration and proliferation, but tubulogenesis in 3D cultures was unaffected by VEGFR-3 blocking and partially hindered by VEGFR-2 blocking. Furthermore, both in vitro and in vivo, while VEGFR-3 blocking had no effect on LEC organization, coneutralization of VEGFR-2, and VEGFR- 3 completely prevented lymphatic organization. Our findings demonstrate that cooperative signaling of VEGFR-2 and -3 is necessary for lymphatic migration and proliferation, but VEGFR-3 is redundant with VEGFR-2 for LEC organization into functional capillaries.
引用
收藏
页码:1003 / 1012
页数:10
相关论文
共 50 条
  • [1] Combined Blockade of VEGFR-2 and VEGFR-3 Inhibits Inflammatory Lymphangiogenesis in Early and Middle Stages
    Yuen, Don
    Pytowski, Bronek
    Chen, Lu
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (05) : 2593 - 2597
  • [2] Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face
    Tokuyama, Wataru
    Mikami, Tetuo
    Masuzawa, Mikio
    Okayasu, Isao
    [J]. HUMAN PATHOLOGY, 2010, 41 (03) : 407 - 414
  • [3] uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
    Durre, Tania
    Morfoisse, Florent
    Erpicum, Charlotte
    Ebroin, Marie
    Blacher, Silvia
    Garcia-Caballero, Melissa
    Deroanne, Christophe
    Louis, Thomas
    Balsat, Cedric
    Van de Velde, Maureen
    Kaijalainen, Seppo
    Kridelka, Frederic
    Engelholm, Lars
    Struman, Ingrid
    Alitalo, Kari
    Behrendt, Niels
    Paupert, Jenny
    Noel, Agnes
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [4] Regulation of lymphangiogenesis in the diaphragm by macrophages and VEGFR-3 signaling
    Alexandra M. Ochsenbein
    Sinem Karaman
    Steven T. Proulx
    Rhea Goldmann
    Jyothi Chittazhathu
    Athanasia Dasargyri
    Chloé Chong
    Jean-Christophe Leroux
    E. Richard Stanley
    Michael Detmar
    [J]. Angiogenesis, 2016, 19 : 513 - 524
  • [5] Regulation of lymphangiogenesis in the diaphragm by macrophages and VEGFR-3 signaling
    Ochsenbein, Alexandra M.
    Karaman, Sinem
    Proulx, Steven T.
    Goldmann, Rhea
    Chittazhathu, Jyothi
    Dasargyri, Athanasia
    Chong, Chloe
    Leroux, Jean-Christophe
    Stanley, E. Richard
    Detmar, Michael
    [J]. ANGIOGENESIS, 2016, 19 (04) : 513 - 524
  • [6] uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis
    Tania Durré
    Florent Morfoisse
    Charlotte Erpicum
    Marie Ebroin
    Silvia Blacher
    Melissa García-Caballero
    Christophe Deroanne
    Thomas Louis
    Cédric Balsat
    Maureen Van de Velde
    Seppo Kaijalainen
    Frédéric Kridelka
    Lars Engelholm
    Ingrid Struman
    Kari Alitalo
    Niels Behrendt
    Jenny Paupert
    Agnès Noel
    [J]. Nature Communications, 9
  • [7] VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis
    Hamada, K
    Oike, Y
    Takakura, N
    Ito, Y
    Jussila, L
    Dumont, DJ
    Alitalo, K
    Suda, T
    [J]. BLOOD, 2000, 96 (12) : 3793 - 3800
  • [8] CLINICAL SIGNIFICANCE OF VEGFR-2 AND VEGFR-3 EXPRESSION IN OVARIAN CANCER PATIENTS
    Klasa-Mazurkiewicz, Dagmara
    Jarzab, Miroslaw
    Milczek, Tomasz
    Lipinska, Barbara
    Emerich, Janusz
    [J]. POLISH JOURNAL OF PATHOLOGY, 2011, 62 (01) : 31 - 40
  • [9] Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
    Wang, Min
    Xu, Yuan
    Wen, Guo-Zhong
    Wang, Qian
    Yuan, Si-Ming
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 4643 - 4654
  • [10] Relative localization of VEGFR-2 and VEGFR-3 in human colorectal, breast and lung cancers
    Smith, Neil
    Baker, Dawn
    James, Neil
    Ratcliffe, Kirsty
    Ashton, Susan
    Sproat, Graham
    Gray, Neil
    Ryan, Anderson
    Jurgensmeier, Juliane
    Womack, Chris
    [J]. CANCER RESEARCH, 2009, 69